Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis [19]

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 4, 2008, Pages 523-525

  Rallis, E ^a,b   Papatheodorou, G ^a   Bimpakis, E ^a   Butanska, D ^a   Menounos, P ^a   Papadakis, P ^a  

^a 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOID;

ADULT; CASE REPORT; CRYOTHERAPY; EPIDERMODYSPLASIA VERRUCIFORMIS; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; LETTER; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; REMISSION; SKIN BIOPSY; SKIN DEFECT; SOLDIER;

ADULT; DERMATOLOGIC AGENTS; EPIDERMODYSPLASIA VERRUCIFORMIS; FACIAL DERMATOSES; HUMANS; ISOTRETINOIN; MALE;

EID: 41149122198     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02394.x     Document Type: Letter

References (4)

1. Grace FK. Epidermodysplasia verruciformis. http://www.e-medicine.com/ derm/topic123.htm.
2. Lowy DR, Androphy EJ. Warts. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SJ et al., eds. Fitzpatrick′ s Dermatology in General Medicine, Vol. II, 5th edn. McGraw Hill, New York, 1999: 2484-2497.
3. Anadolu R, Oskay T, Erdem C et al. Treatment of epidermodysplasia verruciformis with a combination of acitrecin and interferon alfa-2a. J Am Acad Dermatol 2001; 45 296-299.
4. Jablonska S, Obalek S, Wolska H. Follow-up of patients with epidermodysplasia verruciformis treated with etretinate. Dermatologica 1986; 173: 196-201.